Receive case studies from Merck Serono, MHRA, Teva plus many more at Biosimilars and Biobetters

SMi's Biosimilars and Biobetters conference, taking place on 30 September - 1 October 2015 in London, will address pharmacovigilance of biosimilars, patent litigation, market access, product commercialisation barriers and global market developments.
By: SMi Group
 
 
200x200-Biosimilars-and-Biobetters
200x200-Biosimilars-and-Biobetters
LONDON - Sept. 2, 2015 - PRLog -- From the evolving regulatory landscape and product commercialisation barriers , through to advanced structural characterisation techniques and engagement of payers and clinicians on the safety and adoption of biosimilars, in just 4 weeks, SMi's 6th annual Biosimilars and Biobetters conference will provide a platform to engage in scientific discussions and debate the best practices and solutions to improve industry performance. As well as learning from your peers through case studies and interactive debate, don't miss the opportunity to hear from specialists representing big pharma, academia and biotech, for important updates in the field.

Who Will You Meet?
Network with Confirmed Attendees from Organisations Including: AbbVie, Alston & Bird LLP, Anteris Medical GmbH, Arnold & Porter LLP, Boehringer Ingelheim, Bristows LLP, Cinfa Biotech GmbH, Ecole Normale Supérieure de Cachan, Eppendorf, Fresenius Kabi, GfK, Grifols, Harvest Moon Pharmaceuticals, IMS Health UK, Italfarmaco S.p.A., Kantar Health, Kinesys Consulting, Merck Serono, MHRA, Mundipharma, Norwegian Medicines Agency, Newcastle University, SAI MedPartners, Sandoz International GmbH, Sanofi, Selecta Biosciences, SGS Life Science Services, SGS M-Scan Ltd, Teva, University of Basel, Venner Shipley LLP plus many more...

Speaker Panel includes:
• Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals USA, Inc.
• Shahin Kauser, Senior Scientific Assessor, MHRA
• Chris Teale, Vice President Europe, GfK NOP Ltd
• Bracha Timan, Director, Israel Site Head, Global Bioassays & Technology, Global R&D, Teva
• Takashi Kei Kishimoto, Chief Scientific Officer, Selecta Biosciences
• Karsten Roth, Director Clinical Operations, Cinfa Biotech GmbH
• Alan Sheppard, Principal, Global Generics and Biosimilars, IMS Health
• Steinar Madsen, Medical Director, Norwegian Medicines Agency

To view the full speaker line-up and complete two-day conference programme, visit http://www.smi-online.co.uk/2015biosimilars1.asp

Plus, don't forget the two interactive conference workshops:
A: Assessing the Regulatory Framework for Europe and the US – Developing Future Biologics | Led by: Lincoln Tsung, Daniel Kracov, Jennifer Sklenar, Partners, Arnold & Porter (UK) LLP
1:00pm - 5.30pm, 29 September 2015

B: Biosimilars - Understanding the Regulatory Processes and the Commercial Realities | Led by: Peter Wittner, Senior Consultant, Interpharm Consultancy
8:30am - 12.30pm, 2nd October 2015

Contact
SMi Group
***@smi-online.co.uk
End
Source:SMi Group
Email:***@smi-online.co.uk Email Verified
Tags:Biosimilars, Biobetters, Biologics
Industry:Biotech
Location:London City - London, Greater - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share